Amgen Inc. Cedear (AMGNC)

Profile

https://www.amgen.com

Amgen Inc. Cedear represents an interest in Amgen Inc., a global biotechnology company specializing in human therapeutics. The company discovers, develops, manufactures, and delivers innovative biological medicines designed to address serious and often chronic diseases across major therapeutic areas, including oncology, inflammation, general medicine, and rare diseases. Amgen Inc. focuses on complex conditions such as cardiovascular disease, autoimmune disorders, and certain cancers, offering a portfolio of biologic drugs and specialty pharmaceuticals used in clinical treatment settings. Operating under a single human therapeutics segment, it integrates research and development, large-scale biologics manufacturing, and worldwide commercialization to serve patients and healthcare systems in the United States and international markets. Headquartered in Thousand Oaks, California and founded in 1980, Amgen Inc. is recognized as one of the leading biotechnology firms, with its therapies distributed globally through hospital channels, specialist clinics, and major pharmaceutical wholesalers.